The focus of this research is to look into the influence of the Russia-Ukraine conflict on the Pharmaceutical Supply Chain as seen by the general public and supply chain specialists. The study also investigates the public's reaction and the development of resiliency among professionals, industry, and institutions. The major factors that affected the supply chain, particularly in the pharmaceutical business, such as Covid-19 and Brexit, are explained first. Following that, the primary crisis caused by the Russia-Ukraine war and its consequences are examined. The literature review indicates the impact of the conflict on policies, product manufacturing (particularly pharmaceuticals and medical devices), and clinical trials. Furthermore, the study looks at how different governments and businesses manage their supply networks and other departments during catastrophes. It highlights the individual nature of each crisis and the varying responses by different countries by highlighting examples from Covid-19 and the Russia-Ukraine war. Surveys and questionnaires were used to collect information from the general public and specialists on product shortages during the war, with a focus on their business continuity plans in different crises scenarios. The study concludes by outlining the categories of items that experienced shortages and highlighting the efforts taken by professionals at both the personal and corporate levels to mitigate supply chain interruptions. Using a realistic perspective, this study presents an examination of reality as experienced by all survey and interview participants.